How do I find out if I qualify for a recurrent glioblastoma, idh-wildtype study in North Carolina?

Each study lists its eligibility rules — age, diagnosis, prior treatments. On every trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.

Do I have to live in North Carolina to take part?

Not necessarily. These studies have a site in North Carolina, but eligibility is about your health, not your address — some people travel to take part, and a few studies reimburse travel. The study team can tell you what's required.

Does it cost anything to join a recurrent glioblastoma, idh-wildtype trial?

Using Clin2 is always free. Many trials cover the study treatment and related visits; some reimburse travel. The study team explains exactly what's covered before you decide.

Clinical trials · North Carolina

Recurrent Glioblastoma, IDH-Wildtype clinical trials in North Carolina

We’re tracking 3 recruiting recurrent glioblastoma, idh-wildtype studies with a site in North Carolina — including Phase 1 and Phase 1/Phase 2 studies, each written for real people, not researchers.

Recruiting studies in North Carolina

NCT05432804RecruitingPhase 1/Phase 2
Selinexor added to temozolomide for recurring brain glioblastoma
This trial studies whether adding selinexor to the standard chemotherapy temozolomide (with radiation) can better treat glioblastoma that has come back after prior treatment. If you meet specific tumor, health, and lab requirements, the goal is to slow tumor growth or improve symptoms.
Winston-Salem, North CarolinaAges 18 years+
NCT05879367RecruitingPhase 1
Eflornithine plus temozolomide for newly diagnosed brain cancer
This Phase 1 trial studies whether adding eflornithine to temozolomide (chemotherapy) is safe and potentially helpful for people with newly diagnosed glioblastoma or certain astrocytomas after radiation. It aims to find a workable treatment approach by closely monitoring side effects and early tumor responses.
Durham, North CarolinaAges 18 years+
NCT06860594RecruitingPhase 1
Triapine plus radiation for recurrent brain tumors
This trial tests whether adding an experimental drug called triapine to a second round of radiation therapy can help treat brain tumors that have come back after initial treatment. It may be a good option for people with recurrent glioblastoma or astrocytoma who meet safety criteria.
Charlotte, North CarolinaAges 18 years+

Where these studies are running in North Carolina

Institutions with a site for the recruiting recurrent glioblastoma, idh-wildtype studies listed above.

Wake Forest University Health Sciences · 2 studies
Carolinas Medical Center/Levine Cancer Institute
Duke University

What taking part in a recurrent glioblastoma, idh-wildtype study involves

A screening visit first

Before anything else, the study team checks whether you fit — usually a visit with some tests. You can stop at any point, and screening is typically free.

Care at a nearby site

Study visits happen at a clinic or hospital taking part. Many studies cover the cost of the study treatment and related visits, and some reimburse travel.

You stay in control

Taking part is voluntary and you can leave a study at any time, for any reason, without affecting your regular care.

The team decides eligibility

Our fit check is a helpful first read, not a decision. The study team makes the final call after reviewing your health history.

Recurrent Glioblastoma, IDH-Wildtype trials in other states

Common questions

Are there recurrent glioblastoma, idh-wildtype clinical trials in North Carolina?: Yes. We're currently tracking 3 recruiting recurrent glioblastoma, idh-wildtype studies with a site in North Carolina, each rewritten in plain language so you can see what it's testing and who it's for.
How do I find out if I qualify for a recurrent glioblastoma, idh-wildtype study in North Carolina?: Each study lists its eligibility rules — age, diagnosis, prior treatments. On every trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
Do I have to live in North Carolina to take part?: Not necessarily. These studies have a site in North Carolina, but eligibility is about your health, not your address — some people travel to take part, and a few studies reimburse travel. The study team can tell you what's required.
Does it cost anything to join a recurrent glioblastoma, idh-wildtype trial?: Using Clin2 is always free. Many trials cover the study treatment and related visits; some reimburse travel. The study team explains exactly what's covered before you decide.

Not the right time?

New recurrent glioblastoma, idh-wildtype studies open in North Carolina regularly. Set up a health profile and we’ll quietly watch for studies that fit you and email you when one opens.

Get told when a study that fits you opens

Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.